Evidence map›Paper›PMID 34460143›Full record

ArticleAngewandte Chemie (International ed. in English)2021

Pyrrole Hemithioindigo Antimitotics with Near-Quantitative Bidirectional Photoswitching that Photocontrol Cellular Microtubule Dynamics with Single-Cell Precision*.

Alexander Sailer, Joyce C M Meiring, Constanze Heise, Linda N Pettersson, Anna Akhmanova, Julia Thorn-Seshold, Oliver Thorn-Seshold

Open access · hybridAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Optochemical Control of Therapeutic Agents through Photocatalyzed Isomerization.Angewandte Chemie (International ed. in English) · 2022
    Article
  15. Photopharmacology of Antimitotic Agents.International journal of molecular sciences · 2022
    Review
  16. Journal of the American Chemical Society · 2022
    Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Alexander SailerDepartment of Pharmacy, Ludwig-Maximilians University of Munich, Butenandtstrasse 7, 81377, Munich, Germany.ORCID 0000-0003-4140-9956
Joyce C M MeiringDepartment of Biology, Utrecht University, Padualaan 8, 3584, Utrecht, The Netherlands.ORCID 0000-0001-9166-5363
Constanze HeiseDepartment of Pharmacy, Ludwig-Maximilians University of Munich, Butenandtstrasse 7, 81377, Munich, Germany.
Linda N PetterssonDepartment of Pharmacy, Ludwig-Maximilians University of Munich, Butenandtstrasse 7, 81377, Munich, Germany.
Anna AkhmanovaDepartment of Biology, Utrecht University, Padualaan 8, 3584, Utrecht, The Netherlands.ORCID 0000-0002-9048-8614
Julia Thorn-SesholdDepartment of Pharmacy, Ludwig-Maximilians University of Munich, Butenandtstrasse 7, 81377, Munich, Germany.ORCID 0000-0002-4879-4159
Oliver Thorn-SesholdDepartment of Pharmacy, Ludwig-Maximilians University of Munich, Butenandtstrasse 7, 81377, Munich, Germany.ORCID 0000-0003-3981-651X
Ludwig-Maximilians-Universität München · DEUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the first cellular application of the emerging near-quantitative photoswitch pyrrole hemithioindigo, by rationally designing photopharmaceutical PHTub inhibitors of the cytoskeletal protein tubulin. PHTubs allow simultaneous visible-light imaging and photoswitching in live cells, delivering cell-precise photomodulation of microtubule dynamics, and photocontrol over cell cycle progression and cell death. This is the first acute use of a hemithioindigo photopharmaceutical for high-spatiotemporal-resolution biological control in live cells. It additionally demonstrates the utility of near-quantitative photoswitches, by enabling a dark-active design to overcome residual background activity during cellular photopatterning. This work opens up new horizons for high-precision microtubule research using PHTubs and shows the cellular applicability of pyrrole hemithioindigo as a valuable scaffold for photocontrol of a range of other biological targets.

Indexed as

Single-Cell AnalysisAntimitotic AgentsCell CycleCell DeathCell Line, TumorHeLa CellsHumansIndigo CarmineMicrotubulesMolecular StructurePhotochemical ProcessesPyrrolesAntimitotic AgentshemithioindigoIndigo CarminePyrrolescytotoxicityhemithioindigomicrotubule dynamicsphotopharmacologyphotoswitch

Identifiers

PMID34460143
PMCPMC8596636
OpenAlexW3135111030

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.